Zymergen to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Zymergen Inc. announced its participation in the 40th Annual J.P. Morgan Virtual Healthcare Conference, taking place on January 10th, 2022, at 2:15 p.m. ET. The conference presentation will be accessible via a live and archived webcast on the company's website. Zymergen focuses on designing and producing innovative molecules, microbes, and materials, aligning its mission with sustainability and improved product offerings.

EMERYVILLE, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”or the “Company”), today announced the company will be participating in the upcoming 40^th Annual J.P. Morgan Virtual Healthcare Conference.

Zymergen’s management is scheduled to present on Monday, January 10^th at 2:15 p.m. Eastern Time/11:15 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.zymergen.com/.

About Zymergen

Zymergen is a biotech company that designs and produces molecules, microbes and materials for diverse end markets.  We partner with nature to make better products, a better way, for a better world.

Investor Contact
Carrie Mendivil
investors@zymergen.com

Media Contact
Mike Dulin
mdulin@zymergen.com

FAQ

When will Zymergen present at the J.P. Morgan Virtual Healthcare Conference?

Zymergen will present on January 10th, 2022, at 2:15 p.m. Eastern Time.

How can I access Zymergen's presentation at the conference?

The presentation will be available via a live and archived webcast on Zymergen's Investors section of their website.

What is Zymergen's focus as a biotech company?

Zymergen focuses on designing and producing molecules, microbes, and materials for various end markets, emphasizing sustainability.

Where can I find more information about Zymergen?

More information about Zymergen can be found on their official website in the Investors section.